LENZ
LENZ Therapeutics Inc
NASDAQ: LENZ · HEALTHCARE · BIOTECHNOLOGY
$8.98
-0.77% today
Updated 2026-04-30
Market cap
$306.02M
P/E ratio
—
P/S ratio
16.03x
EPS (TTM)
$-2.85
Dividend yield
—
52W range
$8 – $50
Volume
0.9M
LENZ Therapeutics Inc (LENZ) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-18.2%
Last 4 quarters
Revenue YoY growth
+2306.1%
Most recent quarter
EPS YoY growth
-152.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-18.1%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.16 | -25.5% | $16.12 | $16.00 | -0.7% |
| 2025-11-05 | $-0.59 | -47.5% | $28.05 | $22.96 | -18.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.92 | $-1.16 | -25.5% | $1.59M | +2306.1% |
| 2025-09-30 | $-0.40 | $-0.59 | -47.5% | $12.50M | — |
| 2025-06-30 | $-0.61 | $-0.53 | +13.1% | $5.00M | — |
| 2025-03-31 | $-0.47 | $-0.53 | -12.8% | — | — |
| 2024-12-31 | $-0.10 | $-0.46 | -360.0% | $66000.00 | — |
| 2024-09-30 | $-0.43 | $-0.38 | +11.3% | — | — |
| 2024-06-30 | $-0.67 | $-0.40 | +40.3% | — | — |
| 2024-03-31 | $-0.84 | $-3.53 | -320.2% | — | — |
| 2023-12-31 | $-0.13 | $-0.40 | -207.7% | — | — |
| 2023-09-30 | $-0.24 | $-0.24 | +0.0% | — | — |
| 2023-06-30 | $-0.97 | $-6.79 | -600.0% | — | — |
| 2023-03-31 | $-0.40 | $-3.01 | -660.7% | — | — |
Frequently asked questions
Has LENZ Therapeutics Inc beaten earnings estimates?
LENZ Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -18.2% over the last 4 quarters.
How does LENZ stock react to earnings?
LENZ stock has moved an average of -9.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is LENZ Therapeutics Inc's revenue growth rate?
LENZ Therapeutics Inc reported year-over-year revenue growth of +2306.1% in its most recent quarter, with EPS growing -152.2% year-over-year.